MENU
AVIR
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Atea Pharmaceuticals (AVIR) Ownership - Who owns Atea Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
283.66M
P/E Ratio
N/A
Total Cash
502.21M
Projected Growth
N/A
Total Debt
2.03M
Revenue
N/A
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash/Share
5.95
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AVIR
Capitalization
284M
P/E Ratio
N/A
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash
502M
Total Cash/Share
5.95
Total Debt
2.03M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
476M
P/B Ratio
0.60
Cash Flow
N/A
Earnings
-2.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
84K
Current Ratio
19.02
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-203.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-30.97
Shares Held By Institutions
271M
Shares Outstanding - Current
84.4M
Total Liabilities
33.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
23.607
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of vaccines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com